The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kapadia Sandip since year 2005.
The trader's CIK number is 1677141.
At the time of the last reporting, Kapadia Sandip was the Chief Financial Officer of Intercept Pharmaceuticals, Inc. .
(stock ticker symbol ICPT).
See this page for all insider trading activities at Intercept Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-02||ICPT||Intercept Pharmaceuticals, Inc.||Sale||354||58.83||20,826|
|2017-07-03||ICPT||Intercept Pharmaceuticals, Inc.||Sale||1,431||121.59||173,999|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kapadia Sandip (Chief Financial Officer of Intercept Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.